Amit Kumar, PhD is listed as a director on 4 SEC Form D filings by 2 issuers between Feb 2013 and Jul 2024: TherapyMatch, Inc. (New York, NY — other health care — 2024; $100M reported sold to 9 investors) and COPYTELE INC (Melville, NY — other technology — 2013; $3.5M reported sold to 20 investors).
What this means 2 separate companies raised money with this person listed as director, over about 11 years. Across those companies the filings report $103.5M sold in total.
1 of the issuers belongs to the sponsor group Ars (104 issuers, $9.21B reported sold, 2010–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Ars has 104 companies on file and $9.21B reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 5 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Amit Kumar, PhD and found 7 differences, 1 worth asking the sponsor about: Bankruptcy case: Amit Kumar; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.